Issue:
A pharmaceutical client approached DMS to create an economic model focused on cost and revenue losses associated with treatment of an infection-related diarrheal illness in the long term care (LTC) setting.
Solution:
- We constructed a unique, ‘first of its kind’ model incorporating cost and revenue losses associated with treatment of an infection-related diarrheal illness in the LTC setting. A unique feature of the model was to incorporate ‘at risk’ clinical sub-groups where treatment trajectories have a significant impact on cost and revenue flows in the LTC
- A cost-calculator model demonstrating budget impact to hospital providers was also constructed. This model was well received by the end users of the tool (company field teams and clients) for its ease of use and transparency.
- As a consequence of the high degree of client satisfaction with our modeling efforts, DMS continues to be engaged by this client to develop other unique economic models to support their market access efforts.
